Does single-dose oral granisetron have equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy?
Oral granisetron, administered as a single 2-mg dose, provided equivalent total antiemetic control when compared with i.v. ondansetron (32 mg) in patients who received highly emetogenic, cisplatin-based chemotherapy.
The relationship between total FM and location of FM is influenced by maternal obesity.